Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
Cancer Biomarkers : Section a of Disease Markers|December 28, 2020
The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3pAngelika Tölle, Klaus Jung, Frank Friedersdorff, et al.
Urologia Internationalis|April 1, 2020
Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate BiopsiesAnni Schulze, Frank Christoph, Markus Sachs, et al.
Radiology|June 30, 2009
Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parametersTobias Franiel, Lutz Lüdemann, Birgit Rudolph, et al.
Urology|May 9, 2003
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissuesTerukazu Nakamura, Carsten Stephan, Andreas Scorilas, et al.
International Journal of Cancer|April 3, 2016
Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategyFriederike Kendel, Lukas Helbig, Konrad Neumann, et al.
The Journal of Urology|March 16, 2016
Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health IndexCarsten Stephan, Michael Lein, Julia Matalon, et al.
International Journal of Molecular Sciences|May 31, 2017
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMAIlka Kristiansen, Carsten Stephan, Klaus Jung, et al.
Urology|August 30, 2003
An artificial neural network to predict the outcome of repeat prostate biopsiesMesut Remzi, Theodore Anagnostou, Vincent Ravery, et al.
European Urology|December 5, 2006
Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43Carsten Stephan, Hellmuth-A Meyer, Henning Cammann, et al.
Biological Chemistry|June 28, 2006
Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural networkCarsten Stephan, Hellmuth-Alexander Meyer, Henning Cammann, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
Cancer Biomarkers : Section a of Disease Markers|December 28, 2020
The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3pAngelika Tölle, Klaus Jung, Frank Friedersdorff, et al.
Urologia Internationalis|April 1, 2020
Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate BiopsiesAnni Schulze, Frank Christoph, Markus Sachs, et al.
Radiology|June 30, 2009
Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parametersTobias Franiel, Lutz Lüdemann, Birgit Rudolph, et al.
Urology|May 9, 2003
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissuesTerukazu Nakamura, Carsten Stephan, Andreas Scorilas, et al.
International Journal of Cancer|April 3, 2016
Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategyFriederike Kendel, Lukas Helbig, Konrad Neumann, et al.
The Journal of Urology|March 16, 2016
Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health IndexCarsten Stephan, Michael Lein, Julia Matalon, et al.
International Journal of Molecular Sciences|May 31, 2017
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMAIlka Kristiansen, Carsten Stephan, Klaus Jung, et al.
Urology|August 30, 2003
An artificial neural network to predict the outcome of repeat prostate biopsiesMesut Remzi, Theodore Anagnostou, Vincent Ravery, et al.
European Urology|December 5, 2006
Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43Carsten Stephan, Hellmuth-A Meyer, Henning Cammann, et al.
Biological Chemistry|June 28, 2006
Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural networkCarsten Stephan, Hellmuth-Alexander Meyer, Henning Cammann, et al.
Pageof 23